Barclays Boosts Cardinal Health (NYSE:CAH) Price Target to $133.00

Cardinal Health (NYSE:CAH) had its price objective increased by analysts at Barclays from $117.00 to $133.00 in a report issued on Monday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Barclays‘s price objective suggests a potential upside of 17.51% from the stock’s current price.

Other analysts have also issued research reports about the stock. Evercore ISI boosted their price target on shares of Cardinal Health from $105.00 to $115.00 and gave the company an “in-line” rating in a research report on Thursday, August 15th. StockNews.com cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Sunday. Morgan Stanley boosted their price objective on Cardinal Health from $114.00 to $119.00 and gave the company an “overweight” rating in a research note on Thursday, August 15th. JPMorgan Chase & Co. lifted their target price on Cardinal Health from $111.00 to $123.00 and gave the company a “neutral” rating in a report on Wednesday, August 21st. Finally, Citigroup lowered their price target on shares of Cardinal Health from $115.00 to $107.00 and set a “neutral” rating on the stock in a report on Friday, July 19th. One analyst has rated the stock with a sell rating, five have given a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and a consensus price target of $123.00.

Cardinal Health Trading Up 1.1 %

Shares of NYSE CAH opened at $113.18 on Monday. The stock has a fifty day simple moving average of $111.79 and a two-hundred day simple moving average of $104.20. Cardinal Health has a 1-year low of $93.17 and a 1-year high of $119.13. The firm has a market cap of $27.39 billion, a price-to-earnings ratio of 22.02, a price-to-earnings-growth ratio of 1.57 and a beta of 0.60.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Friday, November 1st. The company reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.26. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The company had revenue of $52.28 billion during the quarter, compared to the consensus estimate of $50.90 billion. During the same quarter in the prior year, the company earned $1.73 EPS. The firm’s quarterly revenue was down 4.3% compared to the same quarter last year. Analysts forecast that Cardinal Health will post 7.69 EPS for the current year.

Insider Transactions at Cardinal Health

In other news, insider Jessica L. Mayer sold 17,896 shares of Cardinal Health stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $106.48, for a total transaction of $1,905,566.08. Following the completion of the sale, the insider now directly owns 94,529 shares of the company’s stock, valued at approximately $10,065,447.92. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, insider Jessica L. Mayer sold 17,896 shares of the stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $106.48, for a total transaction of $1,905,566.08. Following the transaction, the insider now directly owns 94,529 shares in the company, valued at approximately $10,065,447.92. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jessica L. Mayer sold 16,573 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $109.39, for a total value of $1,812,920.47. Following the completion of the sale, the insider now owns 75,971 shares of the company’s stock, valued at $8,310,467.69. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 113,963 shares of company stock valued at $12,379,980 in the last quarter. Insiders own 0.09% of the company’s stock.

Institutional Trading of Cardinal Health

Institutional investors have recently added to or reduced their stakes in the business. Mitsubishi UFJ Trust & Banking Corp boosted its holdings in Cardinal Health by 101.1% during the 1st quarter. Mitsubishi UFJ Trust & Banking Corp now owns 321,558 shares of the company’s stock valued at $36,010,000 after acquiring an additional 161,656 shares during the period. State Board of Administration of Florida Retirement System increased its stake in shares of Cardinal Health by 5.2% in the first quarter. State Board of Administration of Florida Retirement System now owns 314,213 shares of the company’s stock worth $35,160,000 after buying an additional 15,663 shares during the period. Alpha Cubed Investments LLC purchased a new position in shares of Cardinal Health in the third quarter worth $371,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. raised its holdings in Cardinal Health by 1.7% during the 1st quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 393,350 shares of the company’s stock valued at $44,016,000 after buying an additional 6,752 shares during the last quarter. Finally, Bessemer Group Inc. grew its holdings in Cardinal Health by 38.7% in the 1st quarter. Bessemer Group Inc. now owns 19,190 shares of the company’s stock worth $2,148,000 after acquiring an additional 5,352 shares during the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.